RxDoctor Payments DataLook up a doctor →

Alicia Carti

Nurse Practitioner · Clifton, NJNPI 1356339956

Payments from drug & device makers

$7,483in general payments, 2019–2025

Across 379 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • Corcept Therapeutics$693
  • Johnson & Johnson$548
  • Pfizer$422
  • Ironwood Pharmaceuticals, Inc$400
  • plus $3K from 39 others

What the payments were for

  • Food & beverage$7,43799%
  • Education$461%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,483 in reported general payments places this provider in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.

See all nurse practitioner providers in New Jersey

Medicare billing

Part B allowed, 2024
$45,359
Medicare patients
385
Services billed
455

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mesalamine16$7,835
ClenpiqSod Picosulf/Mag Ox/Citric Ac27$4,651
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates64$4,088
Pantoprazole Sodium153$2,261
Sucralfate18$1,641
Colestipol Hcl14$1,015
Dicyclomine Hcl42$653
Omeprazole64$626
Famotidine44$461
Hydrocortisone14$153
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$145
Ondansetron Hcl17$110

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Ferring Pharmaceuticals Inc.Clenpiq$293$4,65127 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.

Other nurse practitioner in Clifton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →